Are you Dr. Sacks?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 20 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
75 Francis St
Brigham & Women's Hosp
Boston, MA 02115Phone+1 617-732-6627- Is this information wrong?
Summary
- Dr. David Sacks, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and California. He is an Associate Professor at Brigham & Women's Hospital.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1986 - 1988
MedStar Health/Georgetown-Washington Hospital CenterFellowship, Hematology and Medical Oncology, 1984 - 1985- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1982 - 1984
District of Columbia General HospitalInternship, Internal Medicine, 1981 - 1982
University of Cape Town Faculty of MedicineClass of 1976
Certifications & Licensure
CA State Medical License 1985 - 2026
MA State Medical License 1980 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- 3 citationsActive Rap1-mediated inhibition of choroidal neovascularization requires interactions with IQGAP1 in choroidal endothelial cellsAniket Ramshekar, Haibo Wang, Eric Kunz, Christian Matthew Pappas, Gregory S. Hageman, Brahim Chaqour, David B. Sacks, M. Elizabeth Hartnett> ;FASEB Journal. 2021 Jul 1
- 8 citationsCalmodulin influences MAPK signaling by binding KSR1.Swetha Parvathaneni, Zhigang Li, David B. Sacks> ;The Journal of Biological Chemistry. 2021 Jan 1
- 20 citationsB-Raf autoinhibition in the presence and absence of 14-3-3.Mingzhen Zhang, Hyunbum Jang, Zhigang Li, David B. Sacks, Ruth Nussinov> ;Structure. 2021 Jul 1
- Join now to see all
Press Mentions
- Leishmania Amazonensis Impairs DC Function by Inhibiting CD40 Expression via A2B Adenosine Receptor ActivationApril 26th, 2012
Suny Downstate Hematology Oncology FellowshipJune 8th, 2021
